EXG PulseLinQ Cables (EXGPL)

510(k) clearance · K262816

Sign in to save EXG PulseLinQ Cables (EXGPL) to a watchlist
Decision
Cleared (substantially equivalent)
Decision date
Received by FDA
7 August 2026
Applicant
Cb Innovations, LLC
Generic name
Cable, Transducer And Electrode, Patient, (Including Connector)
Product code
DSA
Specialty (advisory committee)
Cardiovascular
Device class
2
Regulation number
870.2900
Review type
Traditional
FDA AI-enabled device list
Not on the list
Product type
None of the seven digital health types
Digital health
Not tagged. A software product code, FDA's AI-enabled list or a digital health category sets the tag.

Sources

Data provided by the U.S. Food and Drug Administration (openFDA, CC0). openFDA publishes decisions only. Nothing on this page is investment advice.